BRD9 and acute myeloid leukemia: Interestingly, in pediatric B-ALL, NUTM1 fusions have been associated with favorable outcomes [4]; however, the fusion partners described including ACIN1, BRD9, and CUX1 being the most frequent, do not overlap with those identified in our patients or in previously reported AML cases [5].